Catalent
CTLT
#1589
Rank
C$15.11 B
Marketcap
$83.30
Share price
1.13%
Change (1 day)
52.01%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.73

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.80. In 2022 the company made an earnings per share (EPS) of $3.17 a decrease over its 2021 EPS that were of $4.57.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.73-154.56%
2022$3.17-30.58%
2021$4.5779.67%
2020$2.54114.12%
2019$1.19-15%
2018$1.4075.44%
2017$0.80-22.97%
2016$1.03-59.56%
2015$2.55282.05%
2014$0.67-378.2%
2013-$0.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.10-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.05-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.97 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$8.92-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA